Evidence map›Paper›PMID 42272701›Full record

ArticleFrontiers in pediatrics2026

Ling Luo, Zhuoyao Guo, Weicheng Chen, Yanghong Zheng, Chen Chen, Qiang Li, Na Wang, Yingqun Ji, Jing Hua

Abstract readCase Reports
PubMed Full text at PMC Publisher
In one paragraph

Article in Frontiers in pediatrics, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Ling LuoDepartment of Pulmonary and Critical Care Medicine, Shanghai East Hospital Affiliated to Tongji University, Tongji University School of Medicine, Shanghai, China.
Zhuoyao GuoDepartment of Respirology, Children's Hospital of Fudan University, Shanghai, China.
Weicheng ChenDepartment of Cardiothoracic Surgery, Children's Hospital of Fudan University, Shanghai, China.
Yanghong ZhengDepartment of Pulmonary and Critical Care Medicine, Shanghai East Hospital Affiliated to Tongji University, Tongji University School of Medicine, Shanghai, China.
Chen ChenDepartment of Pulmonary and Critical Care Medicine, Shanghai East Hospital Affiliated to Tongji University, Tongji University School of Medicine, Shanghai, China.
Qiang LiDepartment of Pulmonary and Critical Care Medicine, Shanghai East Hospital Affiliated to Tongji University, Tongji University School of Medicine, Shanghai, China.
Na WangDepartment of Pulmonary and Critical Care Medicine, Shanghai East Hospital Affiliated to Tongji University, Tongji University School of Medicine, Shanghai, China.
Yingqun JiDepartment of Pulmonary and Critical Care Medicine, Shanghai East Hospital Affiliated to Tongji University, Tongji University School of Medicine, Shanghai, China.
Jing HuaDepartment of Pulmonary and Critical Care Medicine, Shanghai East Hospital Affiliated to Tongji University, Tongji University School of Medicine, Shanghai, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Cystic fibrosis (CF) is a rare autosomal recessive disorder caused by mutations in the cystic fibrosis transmembrane conductance regulator (CFTR) gene. Although relatively common in Caucasian populations, CF is rare in China, where it frequently presents with non-specific respiratory symptoms, leading to delayed diagnosis and frequent coinfections with multidrug-resistant pathogens. Case report: A 21-year-old man presented with a 6-year history of recurrent productive cough and intermittent fever over the past 6 months. Imaging revealed bronchiectasis with evidence of infection. Metagenomic next-generation sequencing of bronchoalveolar lavage fluid identified Conclusion: We report a case of CF in a Chinese patient presenting with nontuberculous mycobacterial infection, a condition rarely documented in East Asian populations. We provide a review of the relevant literature, aiming to emphasize the importance of early recognition of CF, personalized antimicrobial strategies, and improved access to essential medications.

Indexed as

bronchiectasiscase reportCFTR geneCFTR modulatorscystic fibrosisMycobacterium abscessusnontuberculous mycobacteria

Identifiers

PMID42272701
PMCPMC13246695

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.